text: BAD ART LIFE FITOSORBOVIT in the treatment of patients with chronic prostatitis.
  GP ATYUSHEV, VM NAGORNO, Vladivostok
  Today there is no doubt that the health of modern man depends on the level of development of medicine and pharmacology is not more than 10%. The reason is that any medication not only has a curative effect, but also has toxic side effects because it is alien to the body substance. And, unfortunately, the harm caused by prolonged or massive use of pharmacological agents in the treatment of prostatitis, often exceed their benefits. Because of this, in response to receipt of the drug in the body include protective mechanisms. Gastrointestinal tract (GIT) plays in the process leading role.
  Promising direction was the use of biologically active additives (BAA) FITOSORBOVIT production company ART LIFE made on the basis of high quality citrus pectin, containing the main sorbent (polygalacturonic acid) from 63% to 78%. The main purpose of BAS FITOSORBOVIT in the treatment of patients with chronic prostatitis is to study its effectiveness and possible future use. Under our supervision for the period 1998-1999. there were 100 patients (experimental group) and 40 patients (control group) aged from 20 to 65 years. In 50 patients with prostatitis was revealed for the first time in 90 patients with exacerbation of the disease. Of these, 80% noted dysfunction of the gastrointestinal tract.
  Patients of the experimental group received FITOSORBOVIT 2 tablets daily in the morning on an empty stomach for 3-5 days before treatment and in the next 10 days against a background of basic therapy: diet, anti-microbial agents, adaptogens, immune modulators, biostimulants, physiotherapy (hyperthermia, Biofon, massage, AUIB, ozone therapy). Assessment of the gastrointestinal tract included an analysis of the intensity of complaints (abdominal pain, dyspepsia: nausea, belching, heartburn, a violation of stool, decreased appetite).
  In the experimental group after the application FITOSORBOVIT of 80 patients with the presence of abdominal pain, a violation of his chair and decreased appetite in 60 (75%) noted the disappearance of these symptoms, 20 patients remained mild dyspepsia. The remaining 20 patients in treatment in combination with FITOSORBOVIT function of the gastrointestinal tract is not compromised. In 92 patients of this group came the clinical and laboratory remission (with complete elimination of pathogens) for 20-25 days.
  In the control group, 32 patients with concomitant symptoms of the digestive tract treated (without supplements) were observed abdominal pain - 2, dyspepsia - 4, loss of appetite - 2, allergic reactions - 2, which accounted for 10 cases (31,3%) . In 8 patients without clinical symptoms observed in the gastrointestinal tract: an allergic reaction - 2, dyspepsia - 2. The number of side effects was 14 cases (35%). In this group, complete elimination of pathogens was achieved in 30 patients (75%) with a course of treatment of 30-35 days.
  Thus, FITOSORBOVIT established itself as an effective bioadditive aimed at decontamination and removal of decay products of cellular tissue and pathogenic organisms.
  FITOSORBOVIT reduces the harmful effects and increases the effectiveness of drugs, helps reduce diarrheal illness: 92% (experimental group) and 75% (control group). The application of a variety of dietary supplements by the action in each case should be settled individually. In particular, the use of dietary supplements FITOSORBOVIT in this disease has an auxiliary character and could easily be combined with pharmacological agents, increasing their effect and reducing side effects.